Sign In
Buy NBY
$1.47
+0 (+0%)
At Close: Jun 08, 2026
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality eyecare and wound care products, announces a new and en
NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity
06:00pm, Friday, 19'th Apr 2024
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that on April 18, 2024 it received a notice from the NYSE American LLC stating that the Company is b
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports preliminary net revenue for its eyecare and wound care business for the first quarter of 2024 of $2.6
NovaBay Pharmaceuticals, Inc. (NBY) Q4 2023 Earnings Call Transcript
06:43pm, Tuesday, 26'th Mar 2024
NovaBay Pharmaceuticals, Inc. (NBY) Q4 2023 Earnings Call Transcript
NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results
04:05pm, Tuesday, 26'th Mar 2024
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three and 12 months ended December 31, 2023 and provides a business update.
NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024
06:38pm, Monday, 25'th Mar 2024
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and 12 months ended December 31, 2023 after mark
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality eyecare and wound care products, announces that the Com
NovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based Sales
09:00am, Tuesday, 30'th Jan 2024
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) announces a 64% increase in online subscription-based unit sales for its Avenova® Lid & Lash Spray Solution and
EMERYVILLE, Calif. & BOULDER, Colo.--(BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) and Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA) today announced an agreement for the sale and m
NovaBay Pharmaceuticals Partners with Woo University to Educate Eyecare Professionals on the Use of Amniotic Membranes
06:50am, Wednesday, 06'th Dec 2023
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) announces its partnership with Woo University to support the education of eyecare professionals on the use of am
NovaBay Pharmaceuticals, Inc. (NBY) Q3 2023 Earnings Call Transcript
11:43pm, Thursday, 09'th Nov 2023
NovaBay Pharmaceuticals, Inc. (NYSE:NBY ) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET Company Participants Jody Cain - LHA, IR Justin Hall - CEO and General Counsel Tommy Law - Interi
NovaBay Pharmaceuticals Reports Third Quarter 2023 Financial Results
04:05pm, Thursday, 09'th Nov 2023
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three and nine months ended September 30, 2023 and provides a business updat
NovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023
06:50am, Thursday, 02'nd Nov 2023
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and nine months ended September 30, 2023 after m
NovaBay Pharmaceuticals Expands Physician Dispensed Sales Channel with New Avenova Programs
08:00am, Wednesday, 11'th Oct 2023
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality eyecare, skincare and wound care products, announces th
NovaBay Pharmaceuticals to Present at the Dawson James Small Cap Growth Conference
06:50am, Monday, 02'nd Oct 2023
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality eyecare, skincare and wound care products, announces that
